Related Experiment Video

Updated: May 19, 2026

A Neonatal Mouse Spinal Cord Compression Injury Model
13:31

A Neonatal Mouse Spinal Cord Compression Injury Model

Published on: March 27, 2016

The role of mTOR signaling pathway in spinal cord injury

Haruo Kanno1, Hiroshi Ozawa, Akira Sekiguchi

  • 1Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan. kanno-h@isis.ocn.ne.jp

Cell Cycle (Georgetown, Tex.)
|August 17, 2012
PubMed

Insights

Inhibiting the mammalian target of rapamycin (mTOR) pathway with rapamycin after spinal cord injury (SCI) in mice reduced tissue damage and improved locomotor function by boosting autophagy and decreasing neuronal death.

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Biochemistry

Background:

  • The mammalian target of rapamycin (mTOR) pathway regulates critical cellular functions including metabolism, proliferation, and survival.
  • mTOR signaling is implicated in both neuroprotective and neuroregenerative processes within the central nervous system (CNS).
  • Spinal cord injury (SCI) involves complex pathophysiological changes where mTOR's role is not fully understood.

Purpose of the Study:

  • To investigate the neuroprotective and neuroregenerative effects of inhibiting the mTOR pathway in the acute phase of SCI.
  • To elucidate the mechanisms underlying mTOR's role in neuronal damage and functional recovery following SCI.

Main Methods:

  • Administration of rapamycin (an mTOR inhibitor) at four hours post-injury in a mouse model of SCI.
  • Assessment of autophagy activity, neuronal loss, and cell death in the injured spinal cord.
  • Evaluation of locomotor function in the hindlimbs of SCI mice.

Main Results:

  • Rapamycin treatment significantly increased autophagy activity in the injured spinal cord.
  • Inhibition of mTOR with rapamycin reduced neuronal loss and cell death.
  • Rapamycin-treated mice exhibited significantly improved hindlimb locomotor function compared to controls.

Conclusions:

  • Inhibition of mTOR signaling during the acute phase of SCI confers neuroprotection and mitigates secondary damage.
  • Targeting the mTOR pathway with rapamycin shows therapeutic potential for improving outcomes after spinal cord injury.

More Related Videos

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion09:14

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion

Published on: April 5, 2016

Related Concept Videos

Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Spinal Cord Injury ll: Pathophysiology01:14

Spinal Cord Injury ll: Pathophysiology

Spinal cord injury progresses through two interconnected phases: primary injury and secondary injury.Primary InjuryPrimary injury happens at the moment of trauma and involves immediate mechanical damage to the spinal cord.Compression happens when broken vertebrae, herniated discs, or accumulating blood (such as a hematoma) press directly against the spinal cord, distorting its normal shape and function. In cases of contusion, the cord is bruised by a blunt force (like penetrating injuries or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...